659 related items for PubMed ID: 11443185
1. Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans.
Arvat E, Maccagno B, Giordano R, Pellegrino M, Broglio F, Gianotti L, Maccario M, Camanni F, Ghigo E.
J Clin Endocrinol Metab; 2001 Jul; 86(7):3176-81. PubMed ID: 11443185
[Abstract] [Full Text] [Related]
2. The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans.
Grottoli S, Giordano R, Maccagno B, Pellegrino M, Ghigo E, Arvat E.
J Clin Endocrinol Metab; 2002 Oct; 87(10):4616-20. PubMed ID: 12364444
[Abstract] [Full Text] [Related]
3. Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans.
Berardelli R, Karamouzis I, Marinazzo E, Prats E, Picu A, Giordano R, Ghigo E, Arvat E.
Eur J Endocrinol; 2010 Jun; 162(6):1067-74. PubMed ID: 20219855
[Abstract] [Full Text] [Related]
4. Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade.
Giordano R, Bo M, Pellegrino M, Vezzari M, Baldi M, Picu A, Balbo M, Bonelli L, Migliaretti G, Ghigo E, Arvat E.
J Clin Endocrinol Metab; 2005 Oct; 90(10):5656-62. PubMed ID: 16014406
[Abstract] [Full Text] [Related]
5. Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans.
Grottoli S, Maccagno B, Ramunni J, Di Vito L, Giordano R, Gianotti L, DeStefanis S, Camanni F, Ghigo E, Arvat E.
J Endocrinol Invest; 2002 May; 25(5):420-5. PubMed ID: 12035937
[Abstract] [Full Text] [Related]
6. Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans.
Arvat E, Maccagno B, Ramunni J, Maccario M, Giordano R, Broglio F, Camanni F, Ghigo E.
Eur J Endocrinol; 2000 Jul; 143(1):99-104. PubMed ID: 10870037
[Abstract] [Full Text] [Related]
7. Primary hyperaldosteronism is associated with derangement in the regulation of the hypothalamus-pituitary-adrenal axis in humans.
Giordano R, Pellegrino M, Picu A, Bonelli L, Oleandri SE, Pellissetto C, Limone P, Migliaretti G, Maccario M, Ghigo E, Arvat E.
J Endocrinol Invest; 2007 Jul; 30(7):558-63. PubMed ID: 17848838
[Abstract] [Full Text] [Related]
8. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
[Abstract] [Full Text] [Related]
9. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
Arvat E, Maccagno B, Ramunni J, Di Vito L, Broglio F, Deghenghi R, Camanni F, Ghigo E.
Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
[Abstract] [Full Text] [Related]
10. Recovery of responses to ovine corticotropin-releasing hormone after withdrawal of a short course of glucocorticoid.
Brigell DF, Fang VS, Rosenfield RL.
J Clin Endocrinol Metab; 1992 May; 74(5):1036-9. PubMed ID: 1314844
[Abstract] [Full Text] [Related]
11. Effects of carbamazepine on pituitary-adrenal function in healthy volunteers.
Perini GI, Devinsky O, Hauser P, Gallucci WT, Theodore WH, Chrousos GP, Gold PW, Kling MA.
J Clin Endocrinol Metab; 1992 Feb; 74(2):406-12. PubMed ID: 1309836
[Abstract] [Full Text] [Related]
12. The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
Korbonits M, Kaltsas G, Perry LA, Putignano P, Grossman AB, Besser GM, Trainer PJ.
J Clin Endocrinol Metab; 1999 Jul; 84(7):2489-95. PubMed ID: 10404825
[Abstract] [Full Text] [Related]
13. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
Reincke M, Allolio B, Würth G, Winkelmann W.
J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
[Abstract] [Full Text] [Related]
14. Elevated resting and exercise-induced cortisol levels after mineralocorticoid receptor blockade with canrenoate in healthy humans.
Wellhoener P, Born J, Fehm HL, Dodt C.
J Clin Endocrinol Metab; 2004 Oct; 89(10):5048-52. PubMed ID: 15472204
[Abstract] [Full Text] [Related]
15. Role of endogenous arginine vasopressin in potentiating corticotropin-releasing hormone-stimulated corticotropin secretion in man.
Watabe T, Tanaka K, Kumagae M, Itoh S, Kogure M, Hasegawa M, Horiuchi T, Morio K, Takeda F, Ubukata E.
J Clin Endocrinol Metab; 1988 Jun; 66(6):1132-7. PubMed ID: 2836468
[Abstract] [Full Text] [Related]
16. Acute dexamethasone suppression of ACTH secretion stimulated by human corticotrophin releasing hormone, AVP and hypoglycaemia.
Hohnloser J, Von Werder K, Müller OA.
Clin Endocrinol (Oxf); 1989 Aug; 31(2):175-84. PubMed ID: 2557988
[Abstract] [Full Text] [Related]
17. The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans.
Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H.
J Clin Endocrinol Metab; 1998 Sep; 83(9):3339-45. PubMed ID: 9745451
[Abstract] [Full Text] [Related]
18. Dynamics of the regulation of the hypothalamo-pituitary-adrenal (HPA) axis determined using a nonsurgical method for collecting pituitary venous blood from horses.
Alexander SL, Irvine CH, Donald RA.
Front Neuroendocrinol; 1996 Jan; 17(1):1-50. PubMed ID: 8788568
[Abstract] [Full Text] [Related]
19. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F.
J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
[Abstract] [Full Text] [Related]
20. The acute effect of lowering plasma cortisol on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin as revealed by intensive sampling of pituitary venous blood in the normal horse.
Alexander SL, Irvine CH, Livesey JH, Donald RA.
Endocrinology; 1993 Aug; 133(2):860-6. PubMed ID: 8393777
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
